2022
DOI: 10.1080/09273948.2022.2088566
|View full text |Cite
|
Sign up to set email alerts
|

Ciclosporin A Cationic Emulsion 0.1% for the Management of Dry Eye Disease: Facts That Matter for Eye-Care Providers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…[ 108 ] More recently, a newer formulation of Cyclosporin A Cationic Emulsion 0.1% has shown promising results in moderate to severe dry eye patients with improvement in clinical signs evident as early as 4 weeks, though, up to 12 months of treatment is recommended for more sustained effects. [ 109 ] Further studies are required to assess its efficacy in postrefractive surgery dry eye patients.…”
Section: Managementmentioning
confidence: 99%
“…[ 108 ] More recently, a newer formulation of Cyclosporin A Cationic Emulsion 0.1% has shown promising results in moderate to severe dry eye patients with improvement in clinical signs evident as early as 4 weeks, though, up to 12 months of treatment is recommended for more sustained effects. [ 109 ] Further studies are required to assess its efficacy in postrefractive surgery dry eye patients.…”
Section: Managementmentioning
confidence: 99%